Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy
ConditionCongenital Myotonic Dystrophy
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexNot listed
AgeNot listed
SponsorAMO Pharma Limited
About this trial
This treatment plan is limited to a single patient with Congenital Myotonic Dystrophy, who is ineligible or otherwise unable to participate in ongoing clinical trials.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Tideglusib
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov